Diego Eidy Chiba
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Sirtuins and Resveratrol in Medicine 2
-
- Aldose Reductase and Taurine 2
- Co-authors
- Jean Leandro dos Santos (8 shared papers)Guilherme Fernandes (4 shared papers)Daniela Hartmann Jornada (4 shared papers)Chung Man Chin (7 shared papers)Aline Renata Pavan (2 shared papers)Juliana Romano Lopes (1 shared paper)Maria Elisa Lopes Pires (1 shared paper)Cléverton Roberto de Andrade (2 shared papers)
- Journals
- Nutrients (3 papers)Medicinal Chemistry Research (2 papers)Current Medicinal Chemistry (2 papers)Molecules (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- BrazilUnited Kingdom
In The Last Decade
Diego Eidy Chiba
11 papers receiving 500 citations
Peers
Comparison fields: 5 of 92
- Geriatrics and Gerontology 61
- Molecular Medicine 47
- Pharmaceutical Science 44
- Biochemistry 20
- Aging 6
Countries citing papers authored by Diego Eidy Chiba
This map shows the geographic impact of Diego Eidy Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Eidy Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Eidy Chiba more than expected).
Fields of papers citing papers by Diego Eidy Chiba
This network shows the impact of papers produced by Diego Eidy Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Eidy Chiba. The network helps show where Diego Eidy Chiba may publish in the future.
Co-authors
The 13 scholars most cited alongside Diego Eidy Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 233 | |
| 2 | 2017 | 131 | |
| 3 | 2016 | 113 | |
| 4 | 2021 | 13 | |
| 5 | 2019 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2021 | 1 | |
| 8 | 2014 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2021 | 1 |
About Diego Eidy Chiba
Diego Eidy Chiba is a scholar working on Geriatrics and Gerontology, Cell Biology, Epidemiology, Infectious Diseases and Virology, having authored 11 papers that have together received 506 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (2 papers), Aldose Reductase and Taurine (2 papers), HIV/AIDS drug development and treatment (2 papers), Research on Leishmaniasis Studies (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Autophagy in Disease and Therapy (1 paper), Peptidase Inhibition and Analysis (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Geriatrics and Gerontology (61 citations), Molecular Medicine (47 citations), Pharmaceutical Science (44 citations), Biochemistry (20 citations) and Aging (6 citations). Diego Eidy Chiba has collaborated with scholars based in Brazil and United Kingdom. Frequent co-authors include Jean Leandro dos Santos, Guilherme Fernandes, Daniela Hartmann Jornada, Chung Man Chin, Aline Renata Pavan, Juliana Romano Lopes, Maria Elisa Lopes Pires, Cléverton Roberto de Andrade, Cauê Benito Scarim and Marcus Alexandre Mendes Luz. Their work appears in journals such as Nutrients, Medicinal Chemistry Research, Current Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.